{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T20:50:35Z","timestamp":1726260635598},"reference-count":53,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>The purpose of this study was to evaluate the gene transfer capability and tolerability of plasmid DNA\/poly-ethylenimine (PEI) complexes in comparison with adenovirus and naked plasmid DNA in the canine brain.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Plasmid or adenoviral vectors encoding firefly luciferase were injected directly into the cerebral parenchyma of five adult dogs at varying doses and volumes. Serial physical and neurological examinations, as well as blood and cerebrospinal fluid (CSF) analyses, were conducted before and after the surgery for 3 days. Three days after gene delivery, a luciferase activity assay and immunofluorescence analysis were used to test the brain tissue for gene expression.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Injection into the brain parenchyma resulted in gene transfer throughout the cerebrum with every vector tested. Luciferase expression was highest when adenovirus vectors were used. Injection of plasmid DNA\/PEI complexes and naked DNA resulted in similar levels of luciferase expression, which were on average 0.5 to 1.5% of the expression achieved with adenovirus vectors. Immunofluorescent microscopy analysis revealed that plasmid DNA\/PEI complexes transduced mainly neurons, whereas adenovirus transduced mainly astrocytes. No significant acute side effects or neurological complications were observed in any of the dogs. Mononuclear cell counts significantly increased in the CSF after adenovirus injection and modestly increased after injection of plasmid DNA\/PEI complexes, suggesting that a mild, acute inflammatory response occurred in the central nervous system (CNS).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Compared with rodent models that are limited by very small brains, the dog is an excellent preclinical model in which to assess the distribution and safety of emerging gene transfer technologies. In this study, short-term gene transfer was evaluated as a prelude to long-term expression and safety studies. The authors conclude that the viral and nonviral vectors tested were well tolerated and effective at mediating gene transfer throughout a large portion of the canine brain. The nonviral plasmid vectors were less effective than adenovirus, yet they still achieved appreciable gene expression levels. Due to reduced gene transfer efficiency relative to viral vectors, nonviral vectors may be most useful when the expressed protein is secreted or exerts a bystander effect. Nonviral vectors offer an alternative means to genetically modify cells within the CNS of large mammals.<\/jats:p><\/jats:sec>","DOI":"10.3171\/jns-07\/07\/0136","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T12:54:27Z","timestamp":1201179267000},"page":"136-144","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy of nonviral gene transfer in the canine brain"],"prefix":"10.3171","volume":"107","author":[{"given":"Seunguk","family":"Oh","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Elizabeth","family":"Pluhar","sequence":"additional","affiliation":[{"name":"Small Animal Clinical Sciences, University of Minnesota, St. Paul, Minnesota and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"McNeil","sequence":"additional","affiliation":[{"name":"Small Animal Clinical Sciences, University of Minnesota, St. Paul, Minnesota and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt M.","family":"Kroeger","sequence":"additional","affiliation":[{"name":"Gene Therapeutics Research Institute, Cedars\u2013Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Gene Therapeutics Research Institute, Cedars\u2013Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G.","family":"Castro","sequence":"additional","affiliation":[{"name":"Gene Therapeutics Research Institute, Cedars\u2013Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro R.","family":"Lowenstein","sequence":"additional","affiliation":[{"name":"Gene Therapeutics Research Institute, Cedars\u2013Sinai Medical Center, Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Freese","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Ohlfest","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-1070136","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1089\/hum.1996.7.16-1947","article-title":"A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine","volume":"7","author":"Abdallah","year":"1996"},{"key":"b2-1070136","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.ymthe.2004.08.025","article-title":"Inflammatory and antiglioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression","volume":"10","author":"Ali","year":"2004"},{"key":"b3-1070136","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1158\/0008-5472.CAN-04-3434","article-title":"Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model","volume":"65","author":"Ali","year":"2005"},{"key":"b4-1070136","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1089\/10430349950017644","article-title":"Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand","volume":"10","author":"Ambar","year":"1999"},{"key":"b5-1070136","series-title":"Bioconjug Chem","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1021\/bc050083e","article-title":"Linear polyethyleneimine grafted to a hyperbranched poly(ethylene glycol)-like core: a copolymer for gene delivery","volume":"17","author":"Banerjee","year":"2006"},{"key":"b6-1070136","series-title":"Cancer Gene Ther","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/sj.cgt.7700783","article-title":"Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model","volume":"11","author":"Biglari","year":"2004"},{"key":"b7-1070136","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1006\/mthe.1999.0005","article-title":"Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors","volume":"1","author":"Bosch","year":"2000"},{"key":"b8-1070136","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1523\/JNEUROSCI.19-04-01517.1999","article-title":"Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain","volume":"19","author":"Cartmell","year":"1999"},{"key":"b9-1070136","series-title":"Vet J","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.tvjl.2005.07.001","article-title":"Canine epilepsy: What can we learn from human seizure disorders?","volume":"172","author":"Chandler","year":"2006"},{"key":"b10-1070136","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3171\/jns.1998.88.5.0870","article-title":"Selective intraarterial gene delivery into a canine meningioma","volume":"88","author":"Chauvet","year":"1998"},{"key":"b11-1070136","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ymthe.2004.07.021","article-title":"A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting","volume":"10","author":"Chiocca","year":"2004"},{"key":"b12-1070136","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ana.20870","article-title":"Gene therapy of the brain in the dog model of Hurler's syndrome","volume":"60","author":"Ciron","year":"2006"},{"key":"b13-1070136","series-title":"Gene Ther","first-page":"239","article-title":"Lipopoly-saccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus","volume":"1","author":"Cotten","year":"1994"},{"key":"b14-1070136","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/sj.gt.3301147","article-title":"Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-tK","volume":"7","author":"Cowsill","year":"2000"},{"key":"b15-1070136","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1073\/pnas.97.7.3428","article-title":"Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system","volume":"97","author":"Davidson","year":"2000"},{"key":"b16-1070136","series-title":"J Virol Methods","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0166-0934(95)01973-1","article-title":"Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks","volume":"56","author":"Dion","year":"1996"},{"key":"b17-1070136","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/cncr.20653","article-title":"Intratumoral administration of a 1, 2-dimyristyloxypro-pyl-3\u2013dimethylhydroxyethyl ammonium bromide\/dioleoylphos-phatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma","volume":"101","author":"Galanis","year":"2004"},{"key":"b18-1070136","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ymthe.2005.11.008","article-title":"CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"13","author":"Griffey","year":"2006"},{"key":"b19-1070136","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/hum.2005.16.35","article-title":"Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy","volume":"16","author":"Heinzerling","year":"2005"},{"key":"b20-1070136","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1089\/10430340252837198","article-title":"Critical issues in gene therapy for neurologic disease","volume":"13","author":"Hsich","year":"2002"},{"key":"b21-1070136","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.ymthe.2004.08.002","article-title":"AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study","volume":"10","author":"Immonen","year":"2004"},{"key":"b22-1070136","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/83324","article-title":"Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics","volume":"7","author":"Kay","year":"2001"},{"key":"b23-1070136","series-title":"J Drug Target","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/10611860410001723090","article-title":"Photochemically enhanced gene delivery of EGF receptor-targeted DNA polyplexes","volume":"12","author":"Kloeckner","year":"2004"},{"key":"b24-1070136","series-title":"Bioconjug Chem","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1021\/bc0256087","article-title":"Novel shielded transferrin-polyethylene glycol-polyethylenimine\/DNA complexes for systemic tumor-targeted gene transfer","volume":"14","author":"Kursa","year":"2003"},{"key":"b25-1070136","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1089\/104303402320987842","article-title":"Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus\/adeno-associated virus amplicon vectors","volume":"13","author":"Lam","year":"2002"},{"key":"b26-1070136","series-title":"Mol Cell Neurosci","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1006\/mcne.2001.1084","article-title":"Preferential transfection of adult mouse neural stem cells and their immediate progeny in vivo with polyethylenimine","volume":"19","author":"Lemkine","year":"2002"},{"key":"b27-1070136","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/1531-8249(200007)48:1<27::AID-ANA6>3.0.CO;2-6","article-title":"Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease","volume":"48","author":"Leone","year":"2000"},{"key":"b28-1070136","series-title":"Mol Imaging Biol","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.mibio.2004.09.001","article-title":"Noninvasive of adenovirus tumor retargeting in living subjects by a soluble adenovirus receptor-epidermal growth factor (sCAR-EGF) fusion protein","volume":"6","author":"Liang","year":"2004"},{"key":"b29-1070136","series-title":"Trends Immunol","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1471-4906(01)02063-4","article-title":"Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective","volume":"23","author":"Lowenstein","year":"2002"},{"key":"b30-1070136","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.gt.3302073","article-title":"Virology and immunology of gene therapy, or virology and immunology of high MOI infection with defective viruses","volume":"10","author":"Lowenstein","year":"2003"},{"key":"b31-1070136","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.gt.3302048","article-title":"Inflammation and adaptive immune responses to adenoviral vectors injected into the brain: peculiarities, mechanisms, and consequences","volume":"10","author":"Lowenstein","year":"2003"},{"key":"b32-1070136","series-title":"Curr Opin Mol Ther","first-page":"359","article-title":"Progress and challenges in viral vector-mediated gene transfer to the brain","volume":"4","author":"Lowenstein","year":"2002"},{"key":"b33-1070136","series-title":"Curr Opin Pharmacol","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.coph.2003.10.005","article-title":"Recent advances in the pharmacology of neurological gene therapy","volume":"4","author":"Lowenstein","year":"2004"},{"key":"b34-1070136","series-title":"Neoplasia","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/sj.neo.7900234","article-title":"IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13","volume":"4","author":"Mintz","year":"2002"},{"key":"b35-1070136","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1161\/01.STR.28.4.822","article-title":"Gene transfer to cerebral blood vessels after subarachnoid hemorrhage","volume":"28","author":"Muhonen","year":"1997"},{"key":"b36-1070136","series-title":"J Control Release","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jconrel.2005.10.014","article-title":"Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells","volume":"110","author":"Nimesh","year":"2006"},{"key":"b37-1070136","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/sj.gt.3300900","article-title":"PEGylated DNA\/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery","volume":"6","author":"Ogris","year":"1999"},{"key":"b38-1070136","series-title":"Somat Cell Mol Genet","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1023\/A:1022988008131","article-title":"Tumor-targeted gene transfer with DNA polyplexes","volume":"27","author":"Ogris","year":"2002"},{"key":"b39-1070136","series-title":"Gene Ther Mol Biol","first-page":"181","article-title":"Regulatory sequences of the H19 gene in DNA based therapy of bladder cancer","volume":"8","author":"Ohana","year":"2004"},{"key":"b40-1070136","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ymthe.2005.07.689","article-title":"Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma","volume":"12","author":"Ohlfest","year":"2005"},{"key":"b41-1070136","series-title":"Curr Gene Ther","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2174\/156652305774964749","article-title":"Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies","volume":"5","author":"Ohlfest","year":"2005"},{"key":"b42-1070136","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ymthe.2005.01.011","article-title":"AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease","volume":"11","author":"Passini","year":"2005"},{"key":"b43-1070136","series-title":"Current Protocols in Neuroscience","first-page":"4.23.21","article-title":"Gene transfer into neural cells in vivo using adenoviral vectors","author":"Southgate","year":"2000"},{"key":"b44-1070136","series-title":"J Virol","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1128\/jvi.71.1.145-151.1997","article-title":"The immunogenicity of intracerebral virus infection depends on anatomical site","volume":"71","author":"Stevenson","year":"1997"},{"key":"b45-1070136","series-title":"Vet Pathol","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1354\/vp.41-1-10","article-title":"Morphology, immuno-histochemistry, and genetic alterations in dog astrocytomas","volume":"41","author":"Stoica","year":"2004"},{"key":"b46-1070136","series-title":"J Small Anim Pract","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1748-5827.2000.tb03236.x","article-title":"Idiopathic phenobarbital-responsive hypersialosis in the dog: an unusual form of limbic epilepsy?","volume":"41","author":"Stonehewer","year":"2000"},{"key":"b47-1070136","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1006\/mthe.2000.0224","article-title":"Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain","volume":"3","author":"Thomas","year":"2001"},{"key":"b48-1070136","series-title":"Proc Natl Acad Sci U S A","first-page":"7482","article-title":"Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases","volume":"97","author":"Thomas","year":"2000"},{"key":"b49-1070136","series-title":"Hum Gene Ther","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1089\/104303401750148829","article-title":"Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors","volume":"12","author":"Thomas","year":"2001"},{"key":"b50-1070136","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/ana.10688","article-title":"Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma","volume":"54","author":"Voges","year":"2003"},{"key":"b51-1070136","series-title":"Gene Ther","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/sj.gt.3302735","article-title":"Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice","volume":"13","author":"Watson","year":"2006"},{"key":"b52-1070136","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11060-005-3280-7","article-title":"Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas","volume":"76","author":"Wu","year":"2006"},{"key":"b53-1070136","series-title":"Mol Ther","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1006\/mthe.2001.0479","article-title":"Towards global and long-term neurological gene therapy: unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS","volume":"4","author":"Zermansky","year":"2001"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/107\/1\/article-p136.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/107\/1\/article-p136.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/107\/1\/article-p136.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T01:22:27Z","timestamp":1681348947000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/107\/1\/article-p136.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":53,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/jns-07\/07\/0136","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}